Correlation Between Neuronal Apoptosis Inhibitory Protein ( NAIP ), SMN2 , and SMA Phenotypes: A Tertiary Care Centre Experience From India
American Journal of Medical Genetics Part A · 2025
DOI: 10.1002/ajmg.a.64057 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Medical Genetics Part A, 2025. Verfasst von Soumalya Chakraborty und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Genetics, Department of Pediatrics, All India Institute of Medical Sciences, New Delhi, India. Hauptthemen laut MEDLINE: Survival of Motor Neuron 2 Protein, Neuronal Apoptosis-Inhibitory Protein, Muscular Atrophy, Spinal. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: Institute Research Grant, All India Institute of Medical Sciences, New Delhi, India to Amita Singh.
Abstract (Originalsprache)
SMN2 copy number fails to answer variability in the SMA phenotype completely. We aimed to evaluate the copy number variation in NAIP and SMN2 : c.859G>C and A‐44G variants as disease modifiers and their correlation with the SMA phenotype. Based on the motor milestones achieved, patients with homozygous deletion of SMN1 exon 7 were classified into SMA Types I–IV. The copy numbers of SMN1 exon 8, SMN2 , and NAIP were determined using the MLPA assay. Sanger sequencing was performed for the SMN2 variants. The cohort of 142 patients included nearly equal numbers of patients of SMA Types I, II, and III. The disease severity correlated with the SMN2 and NAIP copy number, with a lower copy number predicting a worse outcome. In addition, we evaluated the SMA genotype ( SMN1 exon 8, SMN2 copy number, and NAIP copy number) as a predictor of SMA severity and found that most of the SMA Type I patients had a genotype of 0–2–0, SMA Type II patients had a genotype of 0–3–1, Type III patients had a genotype of 0–3–2 and 0–3–1, and Type IV patients had a genotype of 0–4–2. None of the patients from the cohort had the two modifier variants. The combined genotype of SMN1 exon 8 copy number– SMN2 copy number– NAIP copy number could accurately predict the SMA phenotype. The absence of SMN2 : c.859G>C and A‐44G variants in any of our patients points to the rarity of these variants in the Indian population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Genetics, Department of Pediatrics, All India Institute of Medical Sciences, New Delhi, India.
- Division of Child Neurology, Department of Pediatrics, All India Institute of Medical Sciences, New Delhi, India.
ORCID-Profile: Shama Perveen, Madhulika Kabra
Förderung
- Institute Research Grant, All India Institute of Medical Sciences, New Delhi, India to Amita Singh
Zitieren
APA
Chakraborty, S., Singh, A., Perveen, S., Chowdhury, M. R., Ali, S., Gupta, N., Gulati, S., & Kabra, M. (2025). Correlation Between Neuronal Apoptosis Inhibitory Protein ( NAIP ), SMN2 , and SMA Phenotypes: A Tertiary Care Centre Experience From India. American Journal of Medical Genetics Part A. https://doi.org/10.1002/ajmg.a.64057
Vancouver
Chakraborty S, Singh A, Perveen S, Chowdhury MR, Ali S, Gupta N, et al. Correlation Between Neuronal Apoptosis Inhibitory Protein ( NAIP ), SMN2 , and SMA Phenotypes: A Tertiary Care Centre Experience From India. American Journal of Medical Genetics Part A. 2025. doi:10.1002/ajmg.a.64057
BibTeX
@article{Chakraborty2025,
author = {Chakraborty, Soumalya and Singh, Amita and Perveen, Shama and Chowdhury, Madhumita Roy and Ali, Salman and Gupta, Neerja and Gulati, Sheffali and Kabra, Madhulika},
title = {Correlation Between Neuronal Apoptosis Inhibitory Protein ( NAIP ), SMN2 , and SMA Phenotypes: A Tertiary Care Centre Experience From India},
journal = {American Journal of Medical Genetics Part A},
year = {2025},
doi = {10.1002/ajmg.a.64057}
}
EUVIMED